Roswell Park’s Stem Cell Transplant Program Recognized by Optum as Center of Excellence - Report - MDSpire

Roswell Park’s Stem Cell Transplant Program Recognized by Optum as Center of Excellence

  • By

  • August 7, 2025

  • 3 min

Share

Clinical Report: Roswell Park’s Stem Cell Transplant Program Recognized by Optum

Overview

Roswell Park Comprehensive Cancer Center has been designated a Center of Excellence by Optum for its stem cell transplant program, achieving a 100% six-month survival rate for allogeneic hematopoietic cell transplantation performed in 2024. This recognition underscores the center's commitment to high-quality care and innovative treatment protocols.

Background

Stem cell transplantation is a critical treatment option for patients with various blood cancers, including leukemia and lymphoma. The quality of care provided by transplant centers significantly impacts patient outcomes, making recognitions like the Center of Excellence designation important for guiding patient choices. Roswell Park's long history and expertise in this field position it as a leader in advancing transplant therapies.

Data Highlights

Roswell Park has performed over 3,450 transplants since 1977, with a 100% six-month survival rate for allogeneic hematopoietic cell transplantation in 2024.

Key Findings

  • Roswell Park has been recognized as a Center of Excellence by Optum for its stem cell transplant program.
  • The center achieved a 100% six-month survival rate for allogeneic hematopoietic cell transplantation in 2024, highlighting its commitment to patient care.
  • Transplant protocols have been enhanced, allowing for reduced hospital stays from four to six weeks to less than two weeks.
  • Roswell Park has a long-standing history in stem cell transplantation, performing over 3,450 transplants since 1977.
  • Optum's evaluation included assessments of clinical expertise, patient outcomes, and quality of care.

Clinical Implications

The recognition of Roswell Park as a Center of Excellence highlights the importance of selecting high-quality transplant centers for optimal patient outcomes. Clinicians should consider referring patients to accredited centers that demonstrate superior survival rates and innovative care protocols, and utilize resources such as national databases to identify these centers.

Conclusion

Roswell Park's designation as a Center of Excellence reflects its commitment to excellence in stem cell transplantation, promising enhanced patient outcomes and innovative treatment approaches, which are critical for patient care.

References

  1. Roswell Park Comprehensive Cancer Center, Roswell Park at ASH 2025 -- Roswell Park at ASH 2025
  2. Roswell Park Comprehensive Cancer Center, Research Leaders Across New York State Form Empire State Cellular Therapy Consortium -- Research Leaders Across New York State Form Empire State Cellular Therapy Consortium
  3. The ASCO Post, Participating in ‘Tremendous Progress’ in Hematologic Oncology, From Chernobyl to Stem Cell Transplantation -- Participating in ‘Tremendous Progress’ in Hematologic Oncology
  4. Nature, Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations | Bone Marrow Transplantation -- Indications for haematopoietic cell transplantation and CAR-T
  5. keck medicine of usc — Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes
  6. Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations | Bone Marrow Transplantation
  7. Summary Slides & Reports
  8. Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review - PubMed

Original Source(s)

Related Content